249 related articles for article (PubMed ID: 37089930)
1. Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells.
Mazurakova A; Koklesova L; Vybohova D; Samec M; Kudela E; Biringer K; Šudomová M; Hassan STS; Kello M; Büsselberg D; Golubnitschaja O; Kubatka P
Front Pharmacol; 2023; 14():1160068. PubMed ID: 37089930
[TBL] [Abstract][Full Text] [Related]
2. Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.
Mazurakova A; Samec M; Koklesova L; Biringer K; Kudela E; Al-Ishaq RK; Pec M; Giordano FA; Büsselberg D; Kubatka P; Golubnitschaja O
EPMA J; 2022 Sep; 13(3):461-486. PubMed ID: 35821883
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy and multiparametric analysis in management of liver malignancies: new concepts of the patient stratification and prognostic approach.
Golubnitschaja O; Polivka J; Yeghiazaryan K; Berliner L
EPMA J; 2018 Sep; 9(3):271-285. PubMed ID: 30174763
[TBL] [Abstract][Full Text] [Related]
4. Wrist actigraphic approach in primary, secondary and tertiary care based on the principles of predictive, preventive and personalised (3P) medicine.
Acker J; Golubnitschaja O; Büttner-Teleaga A; Richter K
EPMA J; 2021 Sep; 12(3):349-363. PubMed ID: 34377218
[TBL] [Abstract][Full Text] [Related]
5. Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations.
Goldstein E; Yeghiazaryan K; Ahmad A; Giordano FA; Fröhlich H; Golubnitschaja O
EPMA J; 2020 Sep; 11(3):505-515. PubMed ID: 32839667
[TBL] [Abstract][Full Text] [Related]
6. Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care.
Mazurakova A; Koklesova L; Samec M; Kudela E; Kajo K; Skuciova V; Csizmár SH; Mestanova V; Pec M; Adamkov M; Al-Ishaq RK; Smejkal K; Giordano FA; Büsselberg D; Biringer K; Golubnitschaja O; Kubatka P
EPMA J; 2022 Jun; 13(2):315-334. PubMed ID: 35437454
[TBL] [Abstract][Full Text] [Related]
7. Predictive, preventive and personalised approach as a conceptual and technological innovation in primary and secondary care of inflammatory bowel disease benefiting affected individuals and populations.
Arosa L; Camba-Gómez M; Golubnitschaja O; Conde-Aranda J
EPMA J; 2024 Mar; 15(1):111-123. PubMed ID: 38463620
[TBL] [Abstract][Full Text] [Related]
8. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker.
O'Conor CJ; Chen T; González I; Cao D; Peng Y
Biomark Med; 2018 Jul; 12(7):813-820. PubMed ID: 29902924
[TBL] [Abstract][Full Text] [Related]
10. Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification.
Fröhlich H; Patjoshi S; Yeghiazaryan K; Kehrer C; Kuhn W; Golubnitschaja O
EPMA J; 2018 Jun; 9(2):175-186. PubMed ID: 29896316
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in treatment stratification for metastatic breast cancer.
Barton S; Swanton C
Drugs; 2011 Nov; 71(16):2099-113. PubMed ID: 22035512
[TBL] [Abstract][Full Text] [Related]
12. Making a complex dental care tailored to the person: population health in focus of predictive, preventive and personalised (3P) medical approach.
Tachalov VV; Orekhova LY; Kudryavtseva TV; Loboda ES; Pachkoriia MG; Berezkina IV; Golubnitschaja O
EPMA J; 2021 Jun; 12(2):129-140. PubMed ID: 33897916
[TBL] [Abstract][Full Text] [Related]
13. Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper.
Golubnitschaja O; Kubatka P; Mazurakova A; Samec M; Alajati A; Giordano FA; Costigliola V; Ellinger J; Ritter M
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158943
[TBL] [Abstract][Full Text] [Related]
14. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach.
Golubnitschaja O; Potuznik P; Polivka J; Pesta M; Kaverina O; Pieper CC; Kropp M; Thumann G; Erb C; Karabatsiakis A; Stetkarova I; Polivka J; Costigliola V
EPMA J; 2022 Dec; 13(4):535-545. PubMed ID: 36415625
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles.
Liskova A; Samec M; Koklesova L; Brockmueller A; Zhai K; Abdellatif B; Siddiqui M; Biringer K; Kudela E; Pec M; Gadanec LK; Šudomová M; Hassan STS; Zulli A; Shakibaei M; Giordano FA; Büsselberg D; Golubnitschaja O; Kubatka P
EPMA J; 2021 Jun; 12(2):155-176. PubMed ID: 34025826
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
17. Screening of acetaminophen-induced alterations in epithelial-to-mesenchymal transition-related expression of microRNAs in a model of stem-like triple-negative breast cancer cells: The possible functional impacts.
Afshar E; Hashemi-Arabi M; Salami S; Peirouvi T; Pouriran R
Gene; 2019 Jun; 702():46-55. PubMed ID: 30898700
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer in Young Women: Status Quo and Advanced Disease Management by a Predictive, Preventive, and Personalized Approach.
Kudela E; Samec M; Kubatka P; Nachajova M; Laucekova Z; Liskova A; Dokus K; Biringer K; Simova D; Gabonova E; Dankova Z; Biskupska Bodova K; Zubor P; Trog D
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31739537
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk assessment: a non-invasive multiparametric approach to stratify patients by MMP-9 serum activity and RhoA expression patterns in circulating leucocytes.
Golubnitschaja O; Yeghiazaryan K; Abraham JA; Schild HH; Costigliola V; Debald M; Kuhn W
Amino Acids; 2017 Feb; 49(2):273-281. PubMed ID: 27812894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
